The latest update is out from M3 ( (JP:2413) ).
M3, Inc. has announced its acquisition of EWEL, Inc., a company specializing in corporate welfare and health services, to expand its preventive healthcare offerings. This strategic move aims to integrate M3’s medical services with EWEL’s employee benefit and health services, enhancing M3’s ability to prevent illnesses and improve health outcomes. Additionally, M3 has formed a business alliance with Tokyu Land, which retains a 37% stake in EWEL, to collaborate in the healthcare and medical fields, leveraging Tokyu Land’s facilities to broaden service accessibility.
More about M3
M3, Inc. operates in the healthcare industry, focusing on providing digital solutions for medical professionals through its web portal ‘m3.com’. The company offers marketing and clinical trial support services for pharmaceutical companies and digital transformation support for clinical settings. M3 is also involved in preventive healthcare initiatives, such as the ‘White Jack Project’.
YTD Price Performance: 7.88%
Average Trading Volume: 212
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $7.95B
For an in-depth examination of 2413 stock, go to TipRanks’ Stock Analysis page.